Biggest News Aggregation in the World
📰 Cell Lines News

Page 2 - Cell Lines News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cell Lines. Real-time updates on events, politics, business and more.

Control of external contaminants during CGT materials production

The quality of materials and reagents used in Cell and Gene Therapy (CGT) production processes plays avital role in determining both the product quality as well as therapeutic safety, and external contaminantsmust be strictly controlled.
Aimee Molineux National Institute For Biological Standards Drug Administration European Medicines Agency International Conference On Harmonization Sponsored Content

Cell Line Development Industry Set to Reach US$ 4,674.8 Million by 2033, With a CAGR of 4.1% | FMI

The global Cell Line Development Industry is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. According to the latest market insights, total cell line product sales are expected to reach US$ 3,124.4 million in 2023, and a staggering US$ 4,674.8...
United States New York Lonza Sartorius Stedim Asia Pacific Merck Kgaa Research Institutes

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cell Line Development Market Soars with a 7.7% CAGR to Reach US$ 10.6 Billion by 2033 | Reveals by F

The Global Cell Line Development Market Anticipated to Reach US$ 5.06 Billion in 2023, Envisioning a 7.7% CAGR from 2023 to 2033, Leading to a Projected US$ 10.6 Billion Market by 2033. In 2022, the Market was Valued at US$ 4.7 Billion.The substantial growth of the cell line development market is predominantly attri...
United States New York Lonza Sartorius Stedim Asia Pacific Consumer Technology Department Of Biotechnology

Synthego and bit.bio expand partnership to build cell engineering platform

Synthego, a leading provider of industrialized genome editing solutions, and bit.bio, the company coding human cells for novel cures, have expanded their partnership to build a platform centered on the implementation of synthetic circuitry in cells for therapeutic application.
Paul Dabrowski Mark Kotter Bio Developments Emerging Markets Cell Amp Gene Therapies Cell Lines

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science